Coated embolization device
View Patent ↗Described are embolization devices having unique bioactive coatings, as well as methods for their manufacture and use. An illustrative embolization device of the invention comprises an embolic body and a coating material comprising biotropic extracellular matrix material immobilized on a surface of the embolic body. The biotropic extracellular matrix material comprises a network of self-assembled collagen fibrils, and comprises at least one bioactive agent retained in the extracellular matrix material, wherein the bioactive agent is selected from the group consisting of a proteoglycan, a growth factor, a glycoprotein, and a glycosaminoglycan. In certain forms, such an extracellular matrix material comprises a remodelable, angiogenic extracellular matrix material, for example, a submucosa material such as but not limited to porcine small intestinal submucosa.
1. An embolization device, comprising:
an embolic body having an elongate primary coil element, the elongate primary coil element having a wire coil about a first axis providing adjacent coil turns that abut one another defining grooves between the adjacent coil turns occurring between adjacent peaks of the coil turns, and wherein the elongate primary coil element is in the shape of a secondary coil about a second axis; and
a coating material immobilized on a surface of said embolic body, said coating material comprising a biotropic extracellular matrix gel, said biotropic extracellular matrix gel comprising a network of self-assembled collagen fibrils and at least one bioactive agent retained in the extracellular matrix gel, the bioactive agent selected from the group consisting of a proteoglycan, a growth factor, a glycoprotein, and a glycosaminoglycan, and wherein said coating material has a greater thickness over said grooves than over said peaks.
2. The device of claim 1 , wherein said network of self-assembled collagen fibrils is generally homogeneous.
3. The device of claim 1 , wherein said coating material is dried.
4. The device of claim 1 , wherein said coating material comprises a single layer of biotropic extracellular matrix gel.
5. The device of claim 1 , wherein said coating material comprises two to six layers of biotropic extracellular matrix gel.
6. The device of claim 1 , wherein said coating material further comprises at least one additional bioactive agent selected from the group consisting of a growth factor, a protein, a proteoglycan, a glycosaminoglycan, a physiologically compatible mineral, an antibiotic, a chemotherapeutic agent, a pharmaceutical, an enzyme, a hormone, and genetic material.
7. The device of claim 1 , wherein coating material has a thickness of 0.5 to 30 μm.
8. The device of claim 1 , wherein coating material has a thickness of 0.5 to 12 μm.
9. The device of claim 1 , wherein said embolization device is not more than 50% stiffer than said embolic body.
10. The device of claim 1 , wherein said embolization device is not more than 10% stiffer than said embolic body.
11. The device of claim 1 , wherein said embolic body comprises a metal.
12. The device of claim 1 , wherein said embolic body comprises a synthetic polymeric material.
13. The device of claim 1 , wherein said coating material surrounds and covers the entire embolic body.
14. The device of claim 1 , wherein said network of self-assembled collagen fibrils is porous so as to provide an open matrix of pores into which new patent tissue can grow following implantation of the embolization device in the body of a patient.
15. The device of claim 3 enclosed within sterile packaging, wherein said biotropic extracellular matrix gel has a nucleic acid level of less than 2 μg/mg.
16. An embolization device, comprising:
an embolic body; and
a multilayered coating comprising at least two individual material layers, said multilayer coating including a reassembled extracellular matrix gel layer formed over a surface of the embolic body so as to provide a coating layer over said surface, wherein the reassembled extracellular matrix gel layer comprises a network of self-assembled collagen fibrils and at least one bioactive agent retained in the reassembled extracellular matrix gel layer, the bioactive agent selected from the group consisting of a proteoglycan, a growth factor, a glycoprotein, and a glyco saminoglycan;
wherein said embolic body comprises an elongate primary coil element, the elongate primary coil element having a wire coil about a first axis, wherein the elongate primary coil element is in the shape of a secondary coil about a second axis providing adjacent coil turns that abut one another, defining grooves between the adjacent coil turns, and wherein said multilayered coating has a greater thickness in said grooves.
17. The embolization device of claim 16 , wherein said network of self-assembled collagen fibrils is generally homogeneous.
18. The embolization device of claim 16 wherein, said multilayered coating includes more than one reassembled extracellular matrix gel layer but less than twenty reassembled extracellular matrix gel layers.
19. The embolization device of claim 18 , wherein said multilayered coating includes an air dried extracellular matrix gel layer and a lyophilized extracellular matrix gel layer.
20. The embolization device of claim 18 , wherein said multilayered coating has a thickness of 0.5 to 30 μm.